s,n,n'-tripropylthiocarbamate has been researched along with Drug Abuse, Intravenous in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, GH; Gardner, E; Iyer, MR; Martinez, MJ; Paik, P; Rice, KC; Sulima, A; Uhl, GR; Xi, ZX | 1 |
| Franck, J; Häggkvist, J; Lindholm, S | 1 |
| Alvelais, J; Gallardo, M; Lozada, R; Magis-Rodriquez, C; Pollini, RA; Strathdee, SA; Vera, A | 1 |
| Brooner, RK; Kidorf, M; King, VL; Kolodner, K; Neufeld, K; Peirce, J | 1 |
| Chang, YJ; Du, J; Evans, E; Hser, YI; Huang, D; Jiang, H; Li, J; Peng, C; Roll, J; Stitzer, ML; Wu, F; Zhang, B; Zhang, C; Zhang, R; Zhao, M | 1 |
| Busch, EL; Elman, I; Langleben, DD; O'Brien, CP | 1 |
| Petry, NM | 1 |
| De Vry, J; Magalas, Z; Tzschentke, TM | 1 |
| Lapeyre-Mestre, M; Montastruc, JL; Roussin, A | 1 |
| Epstein, DH; Ghitza, UE; Preston, KL | 1 |
| Des Jarlais, DC; Garfein, RS; Heckathorn, DD; Santibanez, S; Semaan, S | 1 |
| Comings, DE; Gade, R; Johnson, P; MacMurray, J; Muhleman, D; Saucier, G; Verde, R | 1 |
| Fredholm, BB; Johansson, B; Kuzmin, A; Zvartau, EE | 1 |
| Hughes, JJ | 1 |
2 review(s) available for s,n,n'-tripropylthiocarbamate and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature.
Topics: Anesthetics, Intravenous; Animals; Clinical Trials as Topic; Dopamine; Humans; Models, Animal; Nucleus Accumbens; Propofol; Reward; Substance Abuse, Intravenous | 2007 |
Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling.
Topics: Confidentiality; Data Collection; Drug Users; Duty to Warn; Ethics Committees, Research; Government Regulation; Guidelines as Topic; HIV Infections; Humans; Informed Consent; Motivation; Patient Selection; Professional Role; Reward; Risk Reduction Behavior; Sampling Studies; Substance Abuse, Intravenous; United States | 2009 |
4 trial(s) available for s,n,n'-tripropylthiocarbamate and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Improving substance abuse treatment enrollment in community syringe exchangers.
Topics: Adult; Baltimore; Drug Users; Female; Harm Reduction; Humans; Male; Motivation; Needle-Exchange Programs; Opioid-Related Disorders; Reward; Substance Abuse Treatment Centers; Substance Abuse, Intravenous | 2009 |
Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China.
Topics: Adult; Analysis of Variance; China; Female; HIV Infections; Humans; Male; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Patient Dropouts; Recurrence; Reward; Substance Abuse, Intravenous; Time Factors; Treatment Outcome | 2011 |
Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence.
Topics: Adult; Analysis of Variance; Cues; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Motivation; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pilot Projects; Reward; Substance Abuse, Intravenous; Sucrose; Taste Perception | 2012 |
Contingency management reduces injection-related HIV risk behaviors in heroin and cocaine using outpatients.
Topics: Adolescent; Adult; Aged; Cocaine-Related Disorders; Counseling; Female; Heroin Dependence; HIV Infections; Humans; Male; Methadone; Middle Aged; Narcotics; Reward; Risk Factors; Substance Abuse Treatment Centers; Substance Abuse, Intravenous | 2008 |
8 other study(ies) available for s,n,n'-tripropylthiocarbamate and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist.
Topics: Animals; Catheters, Indwelling; Cocaine-Related Disorders; Conditioning, Psychological; Coumarins; Disease Models, Animal; Gene Expression Regulation; Humans; Injections, Intravenous; Ligands; Mice; Mice, Inbred C57BL; Mice, Knockout; Narcotic Antagonists; Neurons; Receptor-Like Protein Tyrosine Phosphatases, Class 2; Reward; Self Administration; Signal Transduction; Substance Abuse, Intravenous; Toxicity Tests, Acute; Toxicity Tests, Chronic | 2018 |
The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat.
Topics: Amphetamine; Animals; Appetitive Behavior; Behavior, Addictive; Behavior, Animal; Conditioning, Operant; Dopamine Agents; Dose-Response Relationship, Drug; Extinction, Psychological; Feeding Behavior; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Reward; Self Administration; Substance Abuse, Intravenous | 2009 |
The harm inside: injection during incarceration among male injection drug users in Tijuana, Mexico.
Topics: Adult; Condoms; Female; HIV Infections; Humans; Language; Male; Mexico; Needle Sharing; Prisoners; Reimbursement Mechanisms; Reward; Substance Abuse, Intravenous; Substance-Related Disorders; Syphilis; Syringes; Time Factors; Young Adult | 2009 |
Discounting of delayed rewards in substance abusers: relationship to antisocial personality disorder.
Topics: Adult; Antisocial Personality Disorder; Female; Humans; Impulsive Behavior; Internal-External Control; Male; Reward; Risk Factors; Substance Abuse, Intravenous; Substance-Related Disorders; Time Factors | 2002 |
Effects of venlafaxine and desipramine on heroin-induced conditioned place preference in the rat.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Association Learning; Choice Behavior; Conditioning, Classical; Cyclohexanols; Desipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Heroin Dependence; Injections, Intraperitoneal; Male; Premedication; Rats; Rats, Sprague-Dawley; Reward; Self Administration; Social Environment; Substance Abuse, Intravenous; Venlafaxine Hydrochloride | 2006 |
Cannabinoid receptor gene (CNR1): association with i.v. drug use.
Topics: Administration, Inhalation; Administration, Oral; Adult; Alcoholism; Alleles; Amphetamines; Cocaine; Comorbidity; Disease Susceptibility; Evoked Potentials; Female; Gene Frequency; Genotype; Heroin; Heroin Dependence; Humans; Injections, Intravenous; Male; Middle Aged; Receptors, Cannabinoid; Receptors, Drug; Reward; Risk Factors; Smoking; Substance Abuse, Intravenous; Substance-Related Disorders; Trinucleotide Repeats | 1997 |
Caffeine, acting on adenosine A(1) receptors, prevents the extinction of cocaine-seeking behavior in mice.
Topics: Animals; Behavior, Animal; Caffeine; Cocaine; Extinction, Psychological; Male; Mice; Mice, Inbred DBA; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinazolines; Reward; Substance Abuse, Intravenous; Theophylline; Triazoles; Xanthines | 1999 |
Paying injection drug users to educate and recruit their peers: why participant-driven interventions are an ethical public health model.
Topics: Community Health Services; Connecticut; Ethics; Health Education; HIV Infections; Humans; Models, Educational; Motivation; Peer Group; Reward; Social Support; Substance Abuse, Intravenous | 1999 |